Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Iron Deficiency Is Associated With Impaired Myocardial Reperfusion in ST-Segment-Elevation Myocardial Infarction, Influence of the Definition Used

  • Barrabés, José A.|||0000-0001-7062-6277
  • Inserte, Javier|||0000-0003-2283-3591
  • Castellote, Laura
  • Buera Surribas, Irene|||0000-0001-6110-2367
  • Milà Pascual, Laia|||0009-0007-4932-657X
  • Sambola, Antonia
  • Uribarri, Aitor|||0000-0002-6911-7480
  • Vidal Burdeus, María|||0000-0002-9823-5021
  • Aluja, David|||0000-0002-0448-9419
  • Delgado-Tomás, Sara
  • Tobías-Castillo, Pablo E.|||0000-0003-0304-6197
  • Calvo-Barceló, Maria
  • Guala, Andrea|||0000-0002-5006-8164
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • García del Blanco, Bruno|||0000-0002-4527-1600
  • Beneitez Pastor, David|||0000-0002-6541-6600
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
The role of iron deficiency (ID) in ST-segment-elevation myocardial infarction (STEMI) remains unclear. This study aimed to assess whether ID is associated with impaired myocardial reperfusion in STEMI and whether this association is affected by ID definition. We included 942 consecutive patients with STEMI successfully treated with primary percutaneous coronary intervention. ID was defined either as recommended by international guidelines or, alternatively, as ferritin <100 ng/mL, transferrin saturation <20%, or serum iron ≤13 μmol/L. In 595 patients, serum soluble transferrin receptor levels were measured. Impaired myocardial reperfusion was defined as lack of ST-segment resolution ≥50% 60 to 90 minutes after percutaneous coronary intervention. Results: ID prevalence varied across these definitions. Impaired reperfusion was present in 12.7% of patients without ID and 41.0% of those with ID defined by transferrin saturation <20% (P<0.001). This association was less pronounced for serum iron ≤13 μmol/L, weaker for guideline criteria, and absent for high (≥1.59 mg/L) soluble transferrin receptor levels or low ferritin. Transferrin saturation <20%, but not ferritin-based criteria, was associated with poorer clinical course and left ventricular function and higher in-hospital mortality and remained an independent predictor of impaired reperfusion after adjusting for baseline predictors and anemia. Conclusions: ID defined by transferrin saturation <20% is strongly related to impaired ST resolution and predicts a worse in-hospital outcome in patients with STEMI treated with primary percutaneous coronary intervention. The association of other ID criteria with myocardial reperfusion or with the clinical course is weaker or absent. The potential preventive or therapeutic strategies targeting ID in STEMI warrant further investigation.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion

  • Penela, Petronila
  • Inserte Igual, Javier
  • Ramos, Paula
  • Rodríguez Sinovas, Antonio
  • García-Dorado García, David
  • Mayor Jr, Federico
GRK2; AKT; Ischemia-reperfusion, GRK2; AKT; Isquemia-reperfusión, GRK2; AKT; Isquèmia-reperfusió, Background: Identification of signaling pathways altered at early stages after cardiac ischemia/reperfusion (I/R) is crucial to develop timely therapies aimed at reducing I/R injury. The expression of G protein-coupled receptor kinase 2 (GRK2), a key signaling hub, is up-regulated in the long-term in patients and in experimental models of heart failure. However, whether GRK2 levels change at early time points following myocardial I/R and its functional impact during this period remain to be established. Methods: We have investigated the temporal changes of GRK2 expression and their potential relationships with the cardioprotective AKT pathway in isolated rat hearts and porcine preclinical models of I/R. Findings: Contrary to the maladaptive up-regulation of GRK2 reported at later times after myocardial infarction, successive GRK2 phosphorylation at specific sites during ischemia and early reperfusion elicits GRK2 degradation by the proteasome and calpains, respectively, thus keeping GRK2 levels low during early I/R in rat hearts. Concurrently, I/R promotes decay of the prolyl-isomerase Pin1, a positive regulator of AKT stability, and a marked loss of total AKT protein, resulting in an overall decreased activity of this pro-survival pathway. A similar pattern of concomitant down-modulation of GRK2/AKT/Pin1 protein levels in early I/R was observed in pig hearts. Calpain and proteasome inhibition prevents GRK2/Pin1/AKT degradation, restores bulk AKT pathway activity and attenuates myocardial I/R injury in isolated rat hearts. Interpretation: Preventing transient degradation of GRK2 and AKT during early I/R might improve the potential of endogenous cardioprotection mechanisms and of conditioning strategies., Our laboratories are supported by Instituto de Salud Carlos III, Spain (grant PI-16/00232; RETICS-RIC-RD12/0042/0021 to DGD, co-funded with European Regional Development Fund-FEDER contribution, and grants PI14-00435 and PI17-00576 to PP), by Ministerio de Economía; Industria y Competitividad (MINECO) of Spain (grant SAF2017-84125-R to F.M.); by CIBERCV-Instituto de Salud Carlos III, Spain (grant CB16/11/00479 to DGD and CB16/11/00278 to F.M, co-funded with European Regional Development Fund-FEDER contribution), and Programa de Actividades en Biomedicina de la Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE to F.M. We also acknowledge institutional support to the CBMSO from Fundación Ramón Areces. This work is dedicated to the memory of our colleague and friend Dr. David García-Dorado, who sadly passed away during the final revision stage of this manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction

  • Inserte Igual, Javier
  • Barrabés Riu, José Antonio
  • Aluja Gonzalez, David
  • Bañeras Rius, Jordi
  • Sánchez Sánchez, Ana
  • Mila Pascual, Laia
  • Lidón Corbi, Rosa María
  • De Carvalho Negrao Valente, Filipa Xavier
  • Rafecas Ventosa, Agnès
  • Rodríguez Sinovas, Antonio
  • Benito Villabriga, Begoña
  • Buera Surribas, Irene
  • Ferreira González, Ignacio
  • Beneitez Pastor, David
  • Ruiz Meana, Marisol
  • Miro Casas, Elisabet
  • Rodríguez Palomares, Jose Fernando
  • Sambola Ayala, Antonia
  • Castellote Bellés, Laura
  • Delgado Tomás, Sara
  • Otaegui Irurueta, Imanol
Infarto agudo de miocardio; Sintasa; Deficiencia de hierro, Infart agut de miocardi; Sintasa; Deficiència de ferro, Acute myocardial infarction; Synthase; Iron deficiency, In patients with a first anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention, iron deficiency (ID) was associated with larger infarcts, more extensive microvascular obstruction, and higher frequency of adverse left ventricular remodeling as assessed by cardiac magnetic resonance imaging. In mice, an ID diet reduced the activity of the endothelial nitric oxide synthase/soluble guanylate cyclase/protein kinase G pathway in association with oxidative/nitrosative stress and increased infarct size after transient coronary occlusion. Iron supplementation or administration of an sGC activator before ischemia prevented the effects of the ID diet in mice. Not only iron excess, but also ID, may have deleterious effects in the setting of ischemia and reperfusion., This study was funded by Instituto de Salud Carlos III, Spain, through the project PI16/00232 and the research network CIBERCV (CB16/11/00479), both cofunded by European Regional Development Fund, and by the Sociedad Española de Cardiología (Proyecto de Investigación Traslacional en Cardiología 2016). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Iron Deficiency Is Associated With Impaired Myocardial Reperfusion in ST‐Segment–Elevation Myocardial Infarction: Influence of the Definition Used

  • Buera Surribas, Irene
  • Mila Pascual, Laia
  • Delgado Tomás, Sara
  • Tobías-Castillo, Pablo Eduardo
  • Barrabés, José A.
  • Inserte, Javier
  • Castellote Bellés, Laura
  • Sambola Ayala, Antonia
  • Uribarri, Aitor
  • Vidal Burdeus, Maria
  • Aluja, David
  • Calvo-Barceló, Maria
  • Guala, Andrea
  • Rodríguez Palomares, José F
  • García del Blanco, Bruno
  • Beneitez Pastor, David
  • Ferreira-Gonzalez, Ignacio
Acute myocardial infarction; Iron deficiency; Reperfusion, Infarto agudo de miocardio; Deficiencia de hierro; Reperfusión, Infart agut de miocardi; Deficiència de ferro; Reperfusió, Background The role of iron deficiency (ID) in ST‐segment–elevation myocardial infarction (STEMI) remains unclear. This study aimed to assess whether ID is associated with impaired myocardial reperfusion in STEMI and whether this association is affected by ID definition. Methods We included 942 consecutive patients with STEMI successfully treated with primary percutaneous coronary intervention. ID was defined either as recommended by international guidelines or, alternatively, as ferritin <100 ng/mL, transferrin saturation <20%, or serum iron ≤13 μmol/L. In 595 patients, serum soluble transferrin receptor levels were measured. Impaired myocardial reperfusion was defined as lack of ST‐segment resolution ≥50% 60 to 90 minutes after percutaneous coronary intervention. Results ID prevalence varied across these definitions. Impaired reperfusion was present in 12.7% of patients without ID and 41.0% of those with ID defined by transferrin saturation <20% (P<0.001). This association was less pronounced for serum iron ≤13 μmol/L, weaker for guideline criteria, and absent for high (≥1.59 mg/L) soluble transferrin receptor levels or low ferritin. Transferrin saturation <20%, but not ferritin‐based criteria, was associated with poorer clinical course and left ventricular function and higher in‐hospital mortality and remained an independent predictor of impaired reperfusion after adjusting for baseline predictors and anemia. Conclusions ID defined by transferrin saturation <20% is strongly related to impaired ST resolution and predicts a worse in‐hospital outcome in patients with STEMI treated with primary percutaneous coronary intervention. The association of other ID criteria with myocardial reperfusion or with the clinical course is weaker or absent. The potential preventive or therapeutic strategies targeting ID in STEMI warrant further investigation., This study was funded by Instituto de Salud Carlos III, Spain, through the projects AES PI16/00232 and AES PI23/00068 and the research network CIBERCV (CB16/11/00479), both co‐funded by European Regional Development Fund, and by the Sociedad Española de Cardiología y Fundación Española del Corazón (SEC/FEC‐INV‐BAS 23/11).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion

  • Penela, Petronila
  • Inserte, Javier|||0000-0003-2283-3591
  • Ramos, Paula
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • García-Dorado, David|||0000-0002-1126-1279
  • Mayor, F.
Background: Identification of signaling pathways altered at early stages after cardiac ischemia/reperfusion (I/R) is crucial to develop timely therapies aimed at reducing I/R injury. The expression of G protein-coupled receptor kinase 2 (GRK2), a key signaling hub, is up-regulated in the long-term in patients and in experimental models of heart failure. However, whether GRK2 levels change at early time points following myocardial I/R and its functional impact during this period remain to be established. Methods: We have investigated the temporal changes of GRK2 expression and their potential relationships with the cardioprotective AKT pathway in isolated rat hearts and porcine preclinical models of I/R. Findings: Contrary to the maladaptive up-regulation of GRK2 reported at later times after myocardial infarction, successive GRK2 phosphorylation at specific sites during ischemia and early reperfusion elicits GRK2 degradation by the proteasome and calpains, respectively, thus keeping GRK2 levels low during early I/R in rat hearts. Concurrently, I/R promotes decay of the prolyl-isomerase Pin1, a positive regulator of AKT stability, and a marked loss of total AKT protein, resulting in an overall decreased activity of this pro-survival pathway. A similar pattern of concomitant down-modulation of GRK2/AKT/Pin1 protein levels in early I/R was observed in pig hearts. Calpain and proteasome inhibition prevents GRK2/Pin1/AKT degradation, restores bulk AKT pathway activity and attenuates myocardial I/R injury in isolated rat hearts. Interpretation: Preventing transient degradation of GRK2 and AKT during early I/R might improve the potential of endogenous cardioprotection mechanisms and of conditioning strategies.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction

  • Inserte, Javier|||0000-0003-2283-3591
  • Barrabés, José A.|||0000-0001-7062-6277
  • Aluja, David|||0000-0002-0448-9419
  • Otaegui, Imanol|||0000-0001-6594-3139
  • Bañeras, Jordi|||0000-0002-7395-0862
  • Castellote, Laura
  • Sánchez, Ana
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • Pineda, Victor|||0000-0002-2227-0867
  • Miró-Casas, Elisabet|||0000-0002-2058-5961
  • Milà Pascual, Laia|||0009-0007-4932-657X
  • Lidón, Rosa María|||0000-0001-7008-2716
  • Sambola, Antonia
  • Valente, Filipa|||0000-0002-5569-3292
  • Rafecas, Agnès
  • Ruiz Meana, Marisol|||0000-0002-4067-4638
  • Rodríguez Sinovas, Antonio|||0000-0003-2930-8773
  • Benito Villabriga, Begoña|||0000-0002-8668-1251
  • Buera Surribas, Irene|||0000-0001-6110-2367
  • Delgado-Tomás, Sara
  • Beneitez Pastor, David|||0000-0002-6541-6600
  • Ferreira-Gonzalez, Ignacio|||0000-0002-1208-5561
In patients with a first anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention, iron deficiency (ID) was associated with larger infarcts, more extensive microvascular obstruction, and higher frequency of adverse left ventricular remodeling as assessed by cardiac magnetic resonance imaging. In mice, an ID diet reduced the activity of the endothelial nitric oxide synthase/soluble guanylate cyclase/protein kinase G pathway in association with oxidative/nitrosative stress and increased infarct size after transient coronary occlusion. Iron supplementation or administration of an sGC activator before ischemia prevented the effects of the ID diet in mice. Not only iron excess, but also ID, may have deleterious effects in the setting of ischemia and reperfusion.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Iron Deficiency Is Associated With Impaired Myocardial Reperfusion in ST‐Segment–Elevation Myocardial Infarction: Influence of the Definition Used

  • Buera Surribas, Irene
  • Mila Pascual, Laia
  • Delgado Tomás, Sara
  • Tobías-Castillo, Pablo Eduardo
  • Barrabés, José A.
  • Inserte, Javier
  • Castellote Bellés, Laura
  • Sambola Ayala, Antonia
  • Uribarri, Aitor
  • Vidal Burdeus, Maria
  • Aluja, David
  • Calvo-Barceló, Maria
  • Guala, Andrea
  • Rodríguez Palomares, José F
  • García del Blanco, Bruno
  • Beneitez Pastor, David
  • Ferreira-Gonzalez, Ignacio
Acute myocardial infarction; Iron deficiency; Reperfusion, Infarto agudo de miocardio; Deficiencia de hierro; Reperfusión, Infart agut de miocardi; Deficiència de ferro; Reperfusió, Background The role of iron deficiency (ID) in ST‐segment–elevation myocardial infarction (STEMI) remains unclear. This study aimed to assess whether ID is associated with impaired myocardial reperfusion in STEMI and whether this association is affected by ID definition. Methods We included 942 consecutive patients with STEMI successfully treated with primary percutaneous coronary intervention. ID was defined either as recommended by international guidelines or, alternatively, as ferritin <100 ng/mL, transferrin saturation <20%, or serum iron ≤13 μmol/L. In 595 patients, serum soluble transferrin receptor levels were measured. Impaired myocardial reperfusion was defined as lack of ST‐segment resolution ≥50% 60 to 90 minutes after percutaneous coronary intervention. Results ID prevalence varied across these definitions. Impaired reperfusion was present in 12.7% of patients without ID and 41.0% of those with ID defined by transferrin saturation <20% (P<0.001). This association was less pronounced for serum iron ≤13 μmol/L, weaker for guideline criteria, and absent for high (≥1.59 mg/L) soluble transferrin receptor levels or low ferritin. Transferrin saturation <20%, but not ferritin‐based criteria, was associated with poorer clinical course and left ventricular function and higher in‐hospital mortality and remained an independent predictor of impaired reperfusion after adjusting for baseline predictors and anemia. Conclusions ID defined by transferrin saturation <20% is strongly related to impaired ST resolution and predicts a worse in‐hospital outcome in patients with STEMI treated with primary percutaneous coronary intervention. The association of other ID criteria with myocardial reperfusion or with the clinical course is weaker or absent. The potential preventive or therapeutic strategies targeting ID in STEMI warrant further investigation., This study was funded by Instituto de Salud Carlos III, Spain, through the projects AES PI16/00232 and AES PI23/00068 and the research network CIBERCV (CB16/11/00479), both co‐funded by European Regional Development Fund, and by the Sociedad Española de Cardiología y Fundación Española del Corazón (SEC/FEC‐INV‐BAS 23/11).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion

  • Penela, Petronila
  • Inserte Igual, Javier
  • Ramos, Paula
  • Rodríguez Sinovas, Antonio
  • García-Dorado García, David
  • Mayor Jr, Federico
GRK2; AKT; Ischemia-reperfusion, GRK2; AKT; Isquemia-reperfusión, GRK2; AKT; Isquèmia-reperfusió, Background: Identification of signaling pathways altered at early stages after cardiac ischemia/reperfusion (I/R) is crucial to develop timely therapies aimed at reducing I/R injury. The expression of G protein-coupled receptor kinase 2 (GRK2), a key signaling hub, is up-regulated in the long-term in patients and in experimental models of heart failure. However, whether GRK2 levels change at early time points following myocardial I/R and its functional impact during this period remain to be established. Methods: We have investigated the temporal changes of GRK2 expression and their potential relationships with the cardioprotective AKT pathway in isolated rat hearts and porcine preclinical models of I/R. Findings: Contrary to the maladaptive up-regulation of GRK2 reported at later times after myocardial infarction, successive GRK2 phosphorylation at specific sites during ischemia and early reperfusion elicits GRK2 degradation by the proteasome and calpains, respectively, thus keeping GRK2 levels low during early I/R in rat hearts. Concurrently, I/R promotes decay of the prolyl-isomerase Pin1, a positive regulator of AKT stability, and a marked loss of total AKT protein, resulting in an overall decreased activity of this pro-survival pathway. A similar pattern of concomitant down-modulation of GRK2/AKT/Pin1 protein levels in early I/R was observed in pig hearts. Calpain and proteasome inhibition prevents GRK2/Pin1/AKT degradation, restores bulk AKT pathway activity and attenuates myocardial I/R injury in isolated rat hearts. Interpretation: Preventing transient degradation of GRK2 and AKT during early I/R might improve the potential of endogenous cardioprotection mechanisms and of conditioning strategies., Our laboratories are supported by Instituto de Salud Carlos III, Spain (grant PI-16/00232; RETICS-RIC-RD12/0042/0021 to DGD, co-funded with European Regional Development Fund-FEDER contribution, and grants PI14-00435 and PI17-00576 to PP), by Ministerio de Economía; Industria y Competitividad (MINECO) of Spain (grant SAF2017-84125-R to F.M.); by CIBERCV-Instituto de Salud Carlos III, Spain (grant CB16/11/00479 to DGD and CB16/11/00278 to F.M, co-funded with European Regional Development Fund-FEDER contribution), and Programa de Actividades en Biomedicina de la Comunidad de Madrid-B2017/BMD-3671-INFLAMUNE to F.M. We also acknowledge institutional support to the CBMSO from Fundación Ramón Areces. This work is dedicated to the memory of our colleague and friend Dr. David García-Dorado, who sadly passed away during the final revision stage of this manuscript.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction

  • Inserte Igual, Javier
  • Barrabés Riu, José Antonio
  • Aluja Gonzalez, David
  • Bañeras Rius, Jordi
  • Sánchez Sánchez, Ana
  • Mila Pascual, Laia
  • Lidón Corbi, Rosa María
  • De Carvalho Negrao Valente, Filipa Xavier
  • Rafecas Ventosa, Agnès
  • Rodríguez Sinovas, Antonio
  • Benito Villabriga, Begoña
  • Buera Surribas, Irene
  • Ferreira González, Ignacio
  • Beneitez Pastor, David
  • Ruiz Meana, Marisol
  • Miro Casas, Elisabet
  • Rodríguez Palomares, Jose Fernando
  • Sambola Ayala, Antonia
  • Castellote Bellés, Laura
  • Delgado Tomás, Sara
  • Otaegui Irurueta, Imanol
Infarto agudo de miocardio; Sintasa; Deficiencia de hierro, Infart agut de miocardi; Sintasa; Deficiència de ferro, Acute myocardial infarction; Synthase; Iron deficiency, In patients with a first anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention, iron deficiency (ID) was associated with larger infarcts, more extensive microvascular obstruction, and higher frequency of adverse left ventricular remodeling as assessed by cardiac magnetic resonance imaging. In mice, an ID diet reduced the activity of the endothelial nitric oxide synthase/soluble guanylate cyclase/protein kinase G pathway in association with oxidative/nitrosative stress and increased infarct size after transient coronary occlusion. Iron supplementation or administration of an sGC activator before ischemia prevented the effects of the ID diet in mice. Not only iron excess, but also ID, may have deleterious effects in the setting of ischemia and reperfusion., This study was funded by Instituto de Salud Carlos III, Spain, through the project PI16/00232 and the research network CIBERCV (CB16/11/00479), both cofunded by European Regional Development Fund, and by the Sociedad Española de Cardiología (Proyecto de Investigación Traslacional en Cardiología 2016). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.